• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA在乳腺癌脑转移中的分子机制新见解及治疗靶点

New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets.

作者信息

Hussen Bashdar Mahmud, Abdullah Khozga Hazhar, Abdullah Snur Rasool, Majeed Nasik Mahmood, Mohamadtahr Sayran, Rasul Mohammed Fatih, Dong Peixin, Taheri Mohammad, Samsami Majid

机构信息

Department of Biomedical Sciences, College of Science, Cihan University-Erbil, Kurdistan Region, 44001, Iraq.

Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Kurdistan Region, Erbil, Iraq.

出版信息

Noncoding RNA Res. 2023 Sep 28;8(4):645-660. doi: 10.1016/j.ncrna.2023.09.003. eCollection 2023 Dec.

DOI:10.1016/j.ncrna.2023.09.003
PMID:37818447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10560790/
Abstract

Brain metastases in breast cancer (BC) patients are often associated with a poor prognosis. Recent studies have uncovered the critical roles of miRNAs in the initiation and progression of BC brain metastasis, highlighting the disease's underlying molecular pathways. miRNA-181c, miRNA-10b, and miRNA-21, for example, are all overexpressed in BC patients. It has been shown that these three miRNAs help tumors grow and metastasize by targeting genes that control how cells work. On the other hand, miRNA-26b5p, miRNA-7, and miRNA-1013p are all downregulated in BC brain metastasis patients. They act as tumor suppressors by controlling the expression of genes related to cell adhesion, angiogenesis, and invasion. Therapeutic miRNA targeting has considerable promise in treating BC brain metastases. Several strategies have been proposed to modulate miRNA expression, including miRNA-Mimics, antagomirs, and small molecule inhibitors of miRNA biogenesis. This review discusses the aberrant expression of miRNAs and metastatic pathways that lead to the spread of BC cells to the brain. It also explores miRNA therapeutic target molecular mechanisms and BC brain metastasis challenges with advanced strategies. The targeting of certain miRNAs opens a new door for the development of novel therapeutic approaches for this devastating disease.

摘要

乳腺癌(BC)患者发生脑转移通常预后较差。最近的研究揭示了微小RNA(miRNA)在BC脑转移发生和发展中的关键作用,突显了该疾病潜在的分子途径。例如,miRNA - 181c、miRNA - 10b和miRNA - 21在BC患者中均过度表达。研究表明,这三种miRNA通过靶向控制细胞功能的基因来帮助肿瘤生长和转移。另一方面,miRNA - 26b5p、miRNA - 7和miRNA - 1013p在BC脑转移患者中均下调。它们通过控制与细胞黏附、血管生成和侵袭相关基因的表达发挥肿瘤抑制作用。靶向治疗性miRNA在治疗BC脑转移方面具有巨大潜力。已经提出了几种调节miRNA表达的策略,包括miRNA模拟物、抗miRNA寡核苷酸和miRNA生物合成的小分子抑制剂。本综述讨论了导致BC细胞扩散至脑的miRNA异常表达和转移途径。还探讨了miRNA治疗靶点的分子机制以及先进策略面临的BC脑转移挑战。针对某些miRNA的靶向治疗为这种毁灭性疾病开发新的治疗方法打开了一扇新的大门。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/5cdd0c1309c9/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/727404a8eebf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/d973d43b0e5f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/3c0d28b5dcb3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/5cbf1c27ace6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/eec641cabba1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/5cdd0c1309c9/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/727404a8eebf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/d973d43b0e5f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/3c0d28b5dcb3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/5cbf1c27ace6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/eec641cabba1/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/10560790/5cdd0c1309c9/gr6.jpg

相似文献

1
New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets.微小RNA在乳腺癌脑转移中的分子机制新见解及治疗靶点
Noncoding RNA Res. 2023 Sep 28;8(4):645-660. doi: 10.1016/j.ncrna.2023.09.003. eCollection 2023 Dec.
2
MicroRNAs as promising biomarkers and potential therapeutic agents in breast cancer management: a comprehensive review.微小RNA作为乳腺癌管理中有前景的生物标志物和潜在治疗剂:一项综合综述。
Ann Med Surg (Lond). 2024 Apr 22;86(6):3543-3550. doi: 10.1097/MS9.0000000000002075. eCollection 2024 Jun.
3
Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.乳腺癌细胞中miRNA-141的下调与细胞迁移和侵袭相关:涉及对ANP32E的靶向作用。
Cancer Med. 2017 Mar;6(3):662-672. doi: 10.1002/cam4.1024. Epub 2017 Feb 21.
4
The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.通过深度测序分析膀胱癌的微小RNA表达特征:miR-195/497簇的功能意义
PLoS One. 2014 Feb 10;9(2):e84311. doi: 10.1371/journal.pone.0084311. eCollection 2014.
5
Recent advances in novel miRNA mediated approaches for targeting breast cancer.用于靶向乳腺癌的新型miRNA介导方法的最新进展。
J Drug Target. 2023 Sep;31(8):777-793. doi: 10.1080/1061186X.2023.2240979. Epub 2023 Aug 1.
6
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
7
Small players with big roles: microRNAs as targets to inhibit breast cancer progression.小角色,大作用:微小 RNA 作为抑制乳腺癌进展的靶点。
Curr Drug Targets. 2010 Sep;11(9):1059-73. doi: 10.2174/138945010792006762.
8
MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.基于微小RNA的疗法与乳腺癌:从诊断到治疗的新型治疗策略综述
Pharmacol Res. 2015 Jul;97:104-21. doi: 10.1016/j.phrs.2015.04.015. Epub 2015 May 7.
9
The role of miRNAs as biomarkers in breast cancer.微小RNA(miRNAs)作为乳腺癌生物标志物的作用。
Front Oncol. 2024 May 15;14:1374821. doi: 10.3389/fonc.2024.1374821. eCollection 2024.
10
Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications.乳腺癌转移中的异常 miRNA 启动子甲基化和 EMT 相关 miRNA:诊断和治疗意义。
J Cell Physiol. 2018 May;233(5):3729-3744. doi: 10.1002/jcp.26116. Epub 2017 Sep 7.

引用本文的文献

1
Targeted Delivery of Potent Chemical Drugs and RNAi to Drug-Resistant Breast Cancer Using RNA-Nanotechnology and RNA-Ligand Displaying Extracellular vesicles.利用RNA纳米技术和展示RNA配体的细胞外囊泡将强效化学药物和RNA干扰靶向递送至耐药性乳腺癌
RNA Nanomed. 2024;1(1):16-43. doi: 10.59566/isrnn.2024.0101016.
2
Regulation of metastatic organotropism.转移性器官趋向性的调控。
Trends Cancer. 2025 Mar;11(3):216-231. doi: 10.1016/j.trecan.2024.11.012. Epub 2024 Dec 27.
3
Insights into the Mode and Mechanism of Interactions Between RNA and RNA-Binding Proteins.

本文引用的文献

1
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges.通过 CRISPR/Cas 靶向 miRNA 治疗癌症:优势与挑战。
Mil Med Res. 2023 Jul 17;10(1):32. doi: 10.1186/s40779-023-00468-6.
2
Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles.级联 CRISPR/Cas 在不同癌症中 miRNA 调控的诊断应用和治疗选择:前景与障碍。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9557-9575. doi: 10.1007/s00432-023-04747-6. Epub 2023 May 24.
3
CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.
RNA 与 RNA 结合蛋白相互作用模式和机制的研究进展。
Int J Mol Sci. 2024 Oct 22;25(21):11337. doi: 10.3390/ijms252111337.
4
Shedding Light on the Molecular Diversities of miRNA in Cancer- an Exquisite Mini Review.揭示癌症中miRNA的分子多样性——一篇精妙的小型综述
Mol Biotechnol. 2024 Nov 4. doi: 10.1007/s12033-024-01312-5.
5
Exploring the dynamic interplay between exosomes and the immune tumor microenvironment: implications for breast cancer progression and therapeutic strategies.探讨外泌体与免疫肿瘤微环境之间的动态相互作用:对乳腺癌进展和治疗策略的影响。
Breast Cancer Res. 2024 Mar 29;26(1):57. doi: 10.1186/s13058-024-01810-z.
CRISPR-Cas 介导的转录调控:CRISPRa 和 CRISPRi 的治疗潜力。
Mol Ther. 2023 Jul 5;31(7):1920-1937. doi: 10.1016/j.ymthe.2023.03.024. Epub 2023 Mar 24.
4
Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy.克服将外泌体用作癌症治疗药物载体的主要挑战的策略。
Cancer Cell Int. 2022 Oct 18;22(1):323. doi: 10.1186/s12935-022-02743-3.
5
Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability.乳腺癌来源外泌体 miRNA 作为转移预测的液体活检生物标志物:具有临床应用转化研究的重点。
Int J Mol Sci. 2022 Aug 19;23(16):9371. doi: 10.3390/ijms23169371.
6
Engineered Macrophage-Membrane-Coated Nanoparticles with Enhanced PD-1 Expression Induce Immunomodulation for a Synergistic and Targeted Antiglioblastoma Activity.工程化巨噬细胞膜包覆纳米颗粒,增强 PD-1 表达,诱导免疫调节,实现胶质母细胞瘤的协同靶向治疗。
Nano Lett. 2022 Aug 24;22(16):6606-6614. doi: 10.1021/acs.nanolett.2c01863. Epub 2022 Aug 10.
7
A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders.神经递质与 microRNAs 在神经心理障碍中的分子相互作用综述。
Mol Neurobiol. 2022 Oct;59(10):6260-6280. doi: 10.1007/s12035-022-02966-5. Epub 2022 Aug 2.
8
Role and mechanism of miR-211 in human cancer.miR-211在人类癌症中的作用及机制。
J Cancer. 2022 Jul 18;13(9):2933-2944. doi: 10.7150/jca.71401. eCollection 2022.
9
The Significance of MicroRNAs in the Molecular Pathology of Brain Metastases.微小RNA在脑转移分子病理学中的意义
Cancers (Basel). 2022 Jul 12;14(14):3386. doi: 10.3390/cancers14143386.
10
An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy.一种用于脑肿瘤靶向性小干扰RNA递送和胶质母细胞瘤免疫治疗的优化可电离阳离子脂质。
Biomaterials. 2022 Aug;287:121645. doi: 10.1016/j.biomaterials.2022.121645. Epub 2022 Jun 22.